DECLARATION OF INTERESTS. KMZ, NV, RKY, CMI, JEM, WW, JSW, and JFD have nothing to disclose. OBM has received subcontracts to Penn State from Mobile Sleep Technologies (National Science Foundation #1622766, National Institutes of Health R43AG056250). C.A.C. has received consulting fees from or served as a paid member of scientific advisory boards for: Bose Corporation; Boston Celtics; Boston Red Sox; Cephalon, Inc.; Columbia River Bar Pilots; Ganésco Inc.; Institute of Digital Media and Child Development; Jazz Pharmaceuticals; Klarman Family Foundation; Koninklijke Philips Electronics, N.V.; Merck & Co. Inc.; Novartis; Purdue Pharma; Quest Diagnostics, Inc.; Samsung Electronics; Sleep Multimedia, Inc.; Teva Pharmaceuticals; Vanda Pharmaceuticals; Washington State Board of Pilotage Commissioners and Zurich Insurance Company, Ltd. CAC has also received education/research support from Cephalon Inc., Jazz Pharmaceuticals, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, National Football League Charities, Optum, Philips Respironics, ResMed Foundation, San Francisco Bar Pilots, Schneider Inc., Simmons, Sysco and Vanda Pharmaceuticals, Inc. The Sleep and Health Education Program of the Harvard Medical School Division of Sleep Medicine (which CAC directs) has received Educational Grant funding from Cephalon, Inc., Jazz Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sanofi-Aventis, Inc., Sepracor, Inc. and Wake Up Narcolepsy. CAC is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker). Since 1985, CAC has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Bombardier, Inc.; Complete General Construction Company; Continental Airlines; FedEx; Greyhound; HG Energy LLC; Purdue Pharma, L.P.; South Carolina Central Railroad CO; Stric-Lan Companies LLC; Texas Premier Resource LLC; and United Parcel Service (UPS). CAC owns or owned an equity interest in Somnus Therapeutics, Inc., and Vanda Pharmaceuticals. He received royalties from the New England Journal of Medicine, McGraw Hill, Houghton Mifflin Harcourt, and Philips Respironics, Inc. for the Actiwatch-2 and Actiwatch-Spectrum devices. CAC’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.
PubMed
